Xavier Blanchet

7PUBLICATIONS
43CO-AUTHORS
Molecular targetsGlycoconjugatesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Micro-manipulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 07, 2024
Mex3a Protects Against Atherosclerosis: Evidence From Mice and Humans.

Donato Santovito, James M Henderson, Kiril Bidzhekov

|Jul 14, 2023
Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual Framework.

Xavier Blanchet, Christian Weber, Philipp von Hundelshausen

|Sep 12, 2022
Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation.

Markus Brandhofer, Adrian Hoffmann, Xavier Blanchet

|Mar 21, 2022
Targeting platelet-derived CXCL12 impedes arterial thrombosis.

Julian Leberzammer, Stijn M Agten, Xavier Blanchet

|Oct 15, 2020
Autophagy unleashes noncanonical microRNA functions.

Donato Santovito, Virginia Egea, Kiril Bidzhekov

|Jun 05, 2020
Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis.

Donato Santovito, Virginia Egea, Kiril Bidzhekov

Pageof 2